Kimpton M, Cerquozzi S, Toupin D, Ianotto J-C, Villleneuve P, Siegal DM, Carrier M, Delluc A. Breaking barriers in rare disease research: a pilot trial of thromboprophylaxis with apixaban versus aspirin in JAK2-Positive myeloproliferative neoplasms. Haematologica; https://doi.org/10.3324/haematol.2026.301040 [Early view].